News
VYGR
3.490
-1.69%
-0.060
Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer?
TipRanks · 3d ago
Weekly Report: what happened at VYGR last week (0630-0704)?
Weekly Report · 6d ago
H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)
TipRanks · 06/30 16:15
Weekly Report: what happened at VYGR last week (0623-0627)?
Weekly Report · 06/30 09:17
Weekly Report: what happened at VYGR last week (0616-0620)?
Weekly Report · 06/23 09:16
Weekly Report: what happened at VYGR last week (0609-0613)?
Weekly Report · 06/16 09:17
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Barchart · 06/10 06:00
Weekly Report: what happened at VYGR last week (0602-0606)?
Weekly Report · 06/09 09:17
Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade)
Seeking Alpha · 06/06 21:02
Voyager Therapeutics Approves Stock Plans at Annual Meeting
TipRanks · 06/05 20:30
Weekly Report: what happened at VYGR last week (0526-0530)?
Weekly Report · 06/02 09:18
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
TipRanks · 05/31 10:05
It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year
Simply Wall St · 05/27 12:00
Weekly Report: what happened at VYGR last week (0519-0523)?
Weekly Report · 05/26 09:18
Weekly Report: what happened at VYGR last week (0512-0516)?
Weekly Report · 05/19 09:17
Voyager Therapeutics demonstrates ALPL receptor-mediated BBB transport
TipRanks · 05/15 11:22
Voyager Therapeutics Announces First Peer-Reviewed Publication Of Data Showing Ability Of Alkaline Phosphatase To Transport Novel AAV Capsid Across The Blood-brain Barrier
Benzinga · 05/15 11:07
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
Barchart · 05/15 06:00
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA)
TipRanks · 05/12 11:20
Weekly Report: what happened at VYGR last week (0505-0509)?
Weekly Report · 05/12 09:17
More
Webull provides a variety of real-time VYGR stock news. You can receive the latest news about Voyager Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company engaged in leveraging the power of human genetics to modify the course of neurological diseases. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.